Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
This study has finished and is no longer accepting participants.
Multiple locations, including Bedford
Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of LY2979165 in Healthy Subjects
This study has finished and is no longer accepting participants.
In SingaporeA Phase 1, Placebo-Controlled, Crossover Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 After First-Time Administration Of Single Ascending Doses To Healthy Adult Subjects
This study has finished and is no longer accepting participants.
In New HavenThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Poland
A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders: Gdansk Depression Ketamine Project
This study has finished and is no longer accepting participants.
In GdanskA Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel®
This study has finished and is no longer accepting participants.
Multiple locations, including AlmeloOutcome of a Novel Person-Centered Treatment Component for Substance Use Treatment
This study has finished and is no longer accepting participants.
In HamptonThis study was withdrawn before enrollment.
In New York
This study has finished and is no longer accepting participants.
In RochesterA Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
This study has finished and is no longer accepting participants.
In BrooklynDo Low Rates of Coercion in Catchment Areas Predict Negative Effects for Persons With Severe Mental Disorders? A Register Study From Norway 2015-2017. Part of Reducing Coercion in Norway (ReCoN)
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase 1, Healthy Volunteer Qualification Of Ligand [11C] PF-04767135 And Randomized Determination Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET
This study ended early.
In New HavenWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.